Table 2.
Clinical, imaging and CSF AD variables from the parent trial, and newly analyzed CSF vascular, inflammatory and immune markers.
| Cognitive and functional tests | Imaging measures | CSF Aβ, Tau and P-tau 181 | Vascular markers | Inflammation and immune markers | |
|---|---|---|---|---|---|
| ADL | Deep WMHV | Aβ 40 | CRP | IL-1α | Eotaxin |
| ADAS-Cog13 | Global WMHV | Aβ 42 | ICAM1 | IL-1β | Eotaxin-3 |
| CDR-SOB | Entorhinal GMV | P-tau 181 | SAA | IL-2 | IP-10 |
| Memory composite | Hippocampal GMV | T-tau | VCAM-1 | IL-5 | MCP-1 |
| Temporal-parietal GMV meta-ROI | Aβ 42/40 ratio | BFGF | IL-6 | MCP-4 | |
| Aβ 42/T-tau | FLT-1 | IL-7 | MDC | ||
| PIGF | IL-8 | MIP-1α | |||
| Tie-2 | IL-10 | MIP-1β | |||
| VEGF-C | IL-13 | TARC | |||
| VEGF-D | IL-17A | IL12:IL23p40 | |||
| VEGF | IL-15 | IFN-γ | |||
| IL-16 | TNF-α | ||||
| TNF-β | |||||